Article in Alzheimer's & Dementia Points to an Additional Unmet Medical Need Targeted by IntelGenx’ Montelukast VersaFilm™
June 06, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, June 06, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that a peer-reviewed paper entitled “2018...
IntelGenx Announces Settlement of Suboxone® Patent Litigation
May 14, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 14, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that all patent litigation between the Company, Par...
IntelGenx Reports First Quarter 2018 Financial Results
May 10, 2018 16:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 10, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the first quarter...